Off-Label Therapies for COVID-19-Are We All In This Together?
- PMID: 32311763
- PMCID: PMC7264670
- DOI: 10.1002/cpt.1862
Off-Label Therapies for COVID-19-Are We All In This Together?
Conflict of interest statement
The authors declared no conflict of interest.
References
-
- Kupferschmidt, K. & Cohen, J. Race to find COVID‐19 treatments accelerates. Science 367, 1412–1413 (2020). - PubMed
-
- McCreary, E. & Pogue, J.M. COVID‐19 treatment: a review of early and emerging options. Open forum infectious diseases <https://academic.oup.com/ofid/advance‐article/doi/10.1093/ofid/ofaa105/5...>. Accessed March 24, 2020. - DOI - PMC - PubMed
-
- Bloomberg . Hospitals stockpile drug trump says could treat Covid‐19 <https://www.bloomberg.com/news/articles/2020‐03‐20/hospitals‐stockpile‐m...>.
-
- Kalil, A.C. Lack of benefit of high‐dose vitamin C, thiamine, and hydrocortisone combination for patients with sepsis. JAMA 323, 419–420 (2020) <https://jamanetwork.com/journals/jama/article‐abstract/2759413>. - PubMed
-
- US Food and Drug Administration . Request for emergency use authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease. <https://www.fda.gov/media/136534/download>.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
